FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

H J Harkins Company Inc dba Pharma Pac Valsartan tablets 160 mg Recall

Valsartan tablets 160 mg, 90-count bottle, Rx Only, Repackaged by H

H J Harkins Company Inc dba Pharma Pac · Grover Beach, CA

Risk level
Class II
Reported by FDA
Aug 8, 2018
Recall ID
D-1022-2018
Check your lot numberHow we source this data

Summary

H J Harkins Company Inc dba Pharma Pac recalled Valsartan tablets 160 mg starting Jul 26, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1022-2018 on Aug 8, 2018. Reason: Carcinogen impurity detected in API used to manufacture drug product. Status: Terminated.

Why it was recalled

Carcinogen impurity detected in API used to manufacture drug product.

Product description

Valsartan tablets 160 mg, 90-count bottle, Rx Only, Repackaged by H.J. Harkins Co, Inc. Grover Beach, CA 93433, NDC 43547-0369-09. Tablet is yellow, capsule-shaped, biconvex, film-coated tablets debossed with 343 on one side and HH on the other side.

Lot numbers, UPCs & expiration codes

Lot # VSA000OV Manufacturer's original lot # 343B17015, exp date 02/19 NDC 43547-0369-09

Where it was sold

Product was distributed to a physician's office.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1022-2018
Classification
Class II
Status
Terminated
Recall initiated
Jul 26, 2018
FDA report date
Aug 8, 2018
Quantity
540 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
H J Harkins Company Inc dba Pharma Pac

Original FDA data

Every field from FDA enforcement report D-1022-2018, exactly as published.

Show all FDA fields
City
Grover Beach
State
CA
Status
Terminated
Country
United States
Event ID
80674
Address
1400 W Grand Ave Ste F
Code information
Lot # VSA000OV Manufacturer's original lot # 343B17015, exp date 02/19 NDC 43547-0369-09
Postal code
93433-4221
Report date
Aug 8, 2018
Product type
Drugs
Recall number
D-1022-2018
Classification
Class II
Recalling firm
H J Harkins Company Inc dba Pharma Pac
Product quantity
540 tablets
Termination date
Jan 18, 2019
Reason for recall
Carcinogen impurity detected in API used to manufacture drug product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Valsartan tablets 160 mg, 90-count bottle, Rx Only, Repackaged by H.J. Harkins Co, Inc. Grover Beach, CA 93433, NDC 43547-0369-09. Tablet is yellow, capsule-shaped, biconvex, film-coated tablets debossed with 343 on one side and HH on the other side.
Distribution pattern
Product was distributed to a physician's office.
Recall initiation date
Jul 26, 2018
Initial firm notification
Letter
Center classification date
Aug 1, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1022-2018, published Aug 8, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls